EUVIMEDEUVIMED entdecken
Crossref

Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant

Hyun-Jun Park, Sun Mi Choi, Kwon Joong Na, Samina Park, Hyun Joo Lee, Young Tae Kim, Woo Hyeon Lim, Soon Ho Yoon, Jong Hyuk Lee, Jimyung Park

The Journal of Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1016/j.jtcvs.2025.03.030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Hyun-Jun Park und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lung Transplantation, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Low muscle mass (LMM) is recognized as a poor prognostic factor in various chronic lung diseases. However, its prognostic impact on recipients of lung transplants remains inconclusive. METHODS: We retrospectively analyzed patients who underwent lung transplantation at a tertiary referral center in South Korea. Pretransplant skeletal muscle mass was quantified at the L1 vertebral level by computed tomography scans of the chest using a commercially available body composition analysis software. Patients were classified into LMM and non-LMM group using a threshold for LMM that had been previously validated in the South Korean population. We then evaluated the prognostic impact of preoperative LMM on clinical outcomes after lung transplantation. RESULTS: A total of 107 patients were included in this analysis, of whom 44 (41.1%) were classified into the LMM group. The median follow-up duration was 958 days posttransplantation. A preoperative LMM was identified as an independent factor associated with a greater risk of overall mortality (adjusted hazard ratio, 2.15; 95% confidence interval, 1.07-4.34). In addition, patients with LMM had a greater risk of developing primary graft dysfunction (adjusted odds ratio, 3.56; 95% confidence interval, 1.25-10.18). At the 1-year follow-up, 37.5% of the patients with baseline LMM had recovered and were reclassified into the non-LMM group, and this improvement was found to mitigate the negative impact of preoperative LMM. CONCLUSIONS: Pretransplant LMM was significantly associated with poor clinical outcomes in recipients of lung transplants. These findings highlight the importance of maintaining adequate muscle mass during the waiting period for lung transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationMuscle, SkeletalSarcopeniaHumansMaleRetrospective StudiesFemaleMiddle AgedAdultRepublic of KoreaTomography, X-Ray ComputedRisk FactorsTreatment OutcomeTime FactorsPrimary Graft DysfunctionBody CompositionRisk Assessment

Stichwörter der Autor:innen

computed tomographylung transplantationmusclesarcopeniasurvival

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea; Seoul National University Cancer Research Institute, Seoul, Republic of Korea.
  • Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: jonghyuklee@snu.ac.kr.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: drjimyung@gmail.com.

Zitieren

APA

Park, H. J., Choi, S. M., Na, K. J., Park, S., Lee, H. J., Kim, Y. T., Lim, W. H., Yoon, S. H., Lee, J. H., & Park, J. (2025). Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2025.03.030

Vancouver

Park HJ, Choi SM, Na KJ, Park S, Lee HJ, Kim YT, et al. Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2025.03.030

BibTeX
@article{Park2025,
  author = {Park, Hyun-Jun and Choi, Sun Mi and Na, Kwon Joong and Park, Samina and Lee, Hyun Joo and Kim, Young Tae and Lim, Woo Hyeon and Yoon, Soon Ho and Lee, Jong Hyuk and Park, Jimyung},
  title = {Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1016/j.jtcvs.2025.03.030}
}
Kostenlos starten →